| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 143.32B | 109.41B | 144.46B | 123.85B | 45.29B | 27.01B |
| Gross Profit | 29.58B | 20.44B | 29.66B | 27.50B | 8.79B | 5.76B |
| EBITDA | 12.21B | -969.00M | 10.08B | 9.21B | -839.16M | 500.83M |
| Net Income | 8.08B | 1.10B | 8.03B | 11.70B | -2.01B | -321.45M |
Balance Sheet | ||||||
| Total Assets | 161.29B | 154.36B | 162.35B | 143.47B | 86.54B | 61.85B |
| Cash, Cash Equivalents and Short-Term Investments | 106.92B | 101.28B | 112.81B | 103.26B | 56.51B | 47.52B |
| Total Debt | 16.92B | 17.82B | 16.34B | 13.55B | 12.26B | 7.84B |
| Total Liabilities | 87.66B | 80.75B | 91.03B | 82.89B | 41.35B | 20.78B |
| Stockholders Equity | 73.12B | 72.65B | 70.87B | 60.14B | 44.86B | 41.06B |
Cash Flow | ||||||
| Free Cash Flow | 8.74B | -12.82B | 8.20B | 44.19B | 2.25B | 4.90B |
| Operating Cash Flow | 14.97B | -8.61B | 15.93B | 50.69B | 7.38B | 8.34B |
| Investing Cash Flow | -45.39B | -703.13M | -41.14B | -12.07M | -4.36B | -4.26B |
| Financing Cash Flow | -504.79M | 767.40M | -415.65M | 185.38M | 5.64B | 16.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$242.71B | 9.90 | 18.03% | 1.95% | 43.98% | -0.46% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$173.19B | 24.70 | 10.49% | 3.41% | 17.13% | -18.63% | |
60 Neutral | HK$124.08B | -5.74 | -984.82% | ― | 33.63% | 36.31% | |
56 Neutral | HK$122.67B | -122.26 | -3.77% | ― | 88.09% | 80.63% | |
52 Neutral | HK$142.33B | 107.16 | 1.55% | ― | -22.22% | -86.30% | |
47 Neutral | HK$67.72B | -4.42 | -7.98% | 1.35% | -10.32% | -1210.80% |